XML 74 R46.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders Equity (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Weighted Average Assumptions
The following weighted average assumptions were used for grants during the following periods:
Years ended December 31,
20252024
Dividend Yieldn/a0.00%
Volatilityn/a74.72%
Risk-Free Interest Raten/a4.17%
Expected Lifen/a3.50 years
Schedule of Stock Options Activity A summary of stock option activity under the Company’s 2014 Plan and 2024 Plan for the year ended December 31, 2025 is as follows:
Stock OptionsNumber of Shares Weighted Average Exercise
Price per Share 		 Weighted Average Remaining
Contractual Term 		 Aggregate Intrinsic Value
  
Outstanding at January 1, 2025281,913$2.71 3.74$3,517,171 
     
Granted-$- -$- 
Exercised(65,673)$4.24 -$747,116 
Expired/Forfeited(16,249)$2.25 3.68$231,902 
     
Outstanding at December 31, 2025199,991$2.25 3.08$2,915,869 
     
Vested and Exercisable at December 31, 202579,190$2.25 3.08$1,154,590 
Schedule of the Restricted Common Stock Activity
A summary of the restricted Common Stock activity under the Company’s 2014 Plan and 2024 Plan for the year ended December 31, 2025 is as follows:
Restricted Stock AwardsShares Weighted Average Grant Date Fair Value per Share Aggregate
Fair Value
   
Balance at January 1, 2025267,586$5.24 $1,402,151 
    
Granted198,018$15.51 $3,071,259 
Vested(231,613)$4.10 $(949,613)
Forfeited(10,703)$9.09 $(97,290)
    
Balance at December 31, 2025223,288$15.35 $3,426,507